Therapy Analysis & Statistics, August 2014

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: therapeutics, biotherapeutics, cancer therapeutics, more »

1-30 of about 4 700 reports

Purchase Reports From Reputable Market Research Publishers

Chronic Lymphocytic Leukaemia: KOL Insight

Chronic Lymphocytic Leukaemia: KOL Insight

  • $ 5 369
  • Industry report
  • May 2014
  • by Firstword Pharma

Chronic lymphocytic leukaemia (CLL) is the most common of the leukaemias, but until recently it has been underserved in terms of effective therapeutic options. However, a revolution in personalised and ...

  • Industries : Therapy
MarketVIEW: allergic immunotherapies

MarketVIEW: allergic immunotherapies

  • $ 4 495
  • Industry report
  • July 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Allergy or Allergic rhinitis is caused by sensitivity to a number of environmental factors including grass, tree and weed pollens, house dust mite and cat dander. Prevalence in adults can range from 17 ...

  • Industries : Therapy
  • Countries : Japan, World, Europe, France, Netherlands, United States, Spain, Italy, Germany, United Kingdom, Denmark
Inhaled COPD Therapeutics Market

Inhaled COPD Therapeutics Market

  • $ 3 850
  • Industry report
  • June 2014
  • by Greystone Research Associates

COPD is not one but a family of conditions, each with its own etiology and treatment challenges. Chronic bronchitis is the inflammation and eventual scarring of the lining of the bronchial tubes. Oral ...

  • Industries : Therapy
Inhaled Asthma Therapeutics Market

Inhaled Asthma Therapeutics Market

  • $ 3 850
  • Industry report
  • June 2014
  • by Greystone Research Associates

Asthma continues to be a health segment with significant incidence and morbidity. There has been significant interest directed toward the development easier-to-use inhalers, primarily because a large segment ...

  • Industries : Therapy
Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

  • $ 3 500
  • Industry report
  • July 2014
  • by GBI Research

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Therapy
  • Countries : France, Canada, Japan, Spain, Italy, Germany, United States, Europe, United Kingdom, World
Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs Summary GBI Research, the leading business intelligence ...

  • Industries : Therapy
  • Countries : World
Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries

Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries Summary GBI Research, the leading business intelligence ...

  • Industries : Therapy
  • Countries : World
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Summary GBI Research, a leading business ...

  • Industries : Therapy
  • Countries : World, Germany, Japan, United States, Europe, North America, Canada, Spain, Italy, France, United Kingdom
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany The Glioblastoma Multiforme (GBM) treatment market is forecast to grow rapidly from $301 million in 2013 to $623 ...

  • Industries : Therapy
  • Countries : World
Companion Diagnostics in Personalized Medicine and Cancer Therapy

Companion Diagnostics in Personalized Medicine and Cancer Therapy

  • $ 3 400
  • Industry report
  • June 2014
  • by TriMark Publications

Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy. This linkage could be important in the therapeutic ...

  • Industries : Therapy
Personalized Medicine in Oncology Partnering Terms and Agreements

Personalized Medicine in Oncology Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • August 2014
  • by Currentpartnering

The Personalized Medicine in Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the personalized medicine in oncology partnering agreements ...

  • Industries : Therapy
Inhaled CNS Therapeutics Market

Inhaled CNS Therapeutics Market

  • $ 2 850
  • Industry report
  • June 2014
  • by Greystone Research Associates

Neurological disorders are highly prevalent worldwide. And while mental and neurological disorders are responsible for about one per cent of deaths, they account for almost 11 per cent of disease burden ...

  • Industries : Therapy
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024

Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024

  • $ 3 036
  • Industry report
  • June 2014
  • by Visiongain

Report Details Kinase inhibitors - a new study showing you trends, R&D and predicted revenues Do you want to find sales potentials of kinase inhibitors? Now get the latest analysis for those cancer treatments. ...

  • Industries : Therapy
  • Countries : World
Global Hodgkins Lymphoma Therapeutics Market 2014-2018

Global Hodgkins Lymphoma Therapeutics Market 2014-2018

  • $ 2 500
  • Industry report
  • August 2014
  • by Infiniti Research Limited

About Hodgkin's Lymphoma Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the ...

  • Industries : Therapy
  • Countries : World
Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2014

Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • July 2014
  • by Global Data

Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2014" provides data on ...

  • Industries : Therapy
  • Countries : World
Postherpetic Neuralgia Global Clinical Trials Review, H2, 2014

Postherpetic Neuralgia Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • July 2014
  • by Global Data

Postherpetic Neuralgia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Postherpetic Neuralgia Global Clinical Trials Review, H2, 2014" provides data on the Postherpetic ...

  • Industries : Therapy
  • Countries : World, United States
Global Hormone Replacement Therapy Market 2014-2018

Global Hormone Replacement Therapy Market 2014-2018

  • $ 2 500
  • Industry report
  • July 2014
  • by Infiniti Research Limited

About Hormone Replacement Therapy Hormone replacement therapy, also known as hormone therapy, is a means of replacing hormones that are no longer being produced by the body. This type of therapy is usually ...

  • Industries : Therapy
  • Countries : World
Inflammation - Pipeline Review, H1 2014

Inflammation - Pipeline Review, H1 2014

  • $ 2 500
  • Company report
  • June 2014
  • by Global Markets Direct

Inflammation - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Inflammation - Pipeline Review, H1 2014', provides an overview of the Inflammation's therapeutic pipeline. This report provides ...

  • Industries : Therapy
Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018

Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018

  • $ 2 500
  • Industry report
  • June 2014
  • by Infiniti Research Limited

About Non-Hodgkin Lymphoma (NHL) and its Diagnostic Procedures Non-Hodgkin lymphoma (NHL) is a condition of the human body leading to the production of abnormal lymphocytes. In normal circumstances, the ...

  • Industries : Therapy
  • Countries : World
Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2014

Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • June 2014
  • by Global Data

Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2014" provides data on the ...

  • Industries : Therapy
  • Countries : World
Neuropathic Pain Global Clinical Trials Review, H1, 2014

Neuropathic Pain Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • June 2014
  • by Global Data

Neuropathic Pain Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Neuropathic Pain Global Clinical Trials Review, H1, 2014" provides data on the Neuropathic Pain clinical ...

  • Industries : Therapy
  • Countries : World
Global Choroidal Neovascularization (CNV) Market 2014-2018.pdf

Global Choroidal Neovascularization (CNV) Market 2014-2018.pdf

  • $ 2 500
  • Industry report
  • May 2014
  • by Infiniti Research Limited

About CNV CNV is defined as a process in which new blood vessels grow in the choroid through the bruch membrane, which is the innermost layer of the choroid, and attack the sub-retinal space. Even though ...

  • Industries : Therapy
  • Countries : World
Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014

Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • May 2014
  • by Global Data

Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014" provides ...

  • Industries : Therapy
  • Countries : World
Protein Kinase Inhibitors Drug Pathway Analyzer 2014

Protein Kinase Inhibitors Drug Pathway Analyzer 2014

  • $ 2 999
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 963 protein kinase inhibitor drugs known to affect more than 250 specific intracellular signaling pathways ...

  • Industries : Therapy
 Diabetic Nephropathy Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Diabetic Nephropathy Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Diabetic Nephropathy- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Hepatic Edema Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Hepatic Edema Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Hepatic Edema- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and ...

  • Industries : Therapy
  • Countries : United States, World
 Congenital Hypoplastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Congenital Hypoplastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Congenital Hypoplastic Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline ...

  • Industries : Therapy
  • Countries : United States
 Diabetic Neuropathic Pain Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Diabetic Neuropathic Pain Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Diabetic Neuropathic Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline ...

  • Industries : Therapy
  • Countries : United States
 Open-Angle Glaucoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Open-Angle Glaucoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Open-Angle Glaucoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Anterior Uveitis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Anterior Uveitis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Anterior Uveitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Therapy
  • Countries : United States, World

About 100 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Biogen Idec

United States

Merck KGaA

Germany

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.